Emergent BioSolutions to supply medical countermeasures to US
Category: #headlines  By Pankaj Singh  Date: 2019-03-02
  • share
  • Twitter
  • Facebook
  • LinkedIn

Emergent BioSolutions to supply medical countermeasures to US

The company would manufacture and deliver several medical countermeasures prescribed by the Department of State including auto-injector training devices, Reactive Skin Decontamination Lotion Kit, and the Trobigard auto-injector

Emergent BioSolutions Inc. has reportedly inked an IDIQ (indefinite-delivery, indefinite-quantity) agreement with the United States’ Department of State to establish a stable, reliable, and long-term supply chain for medical countermeasures to tackle chemical warfare agents.

According to a press release from Emergent BioSolutions, the agreement consists of a five-year base period of performance with five one-year option periods.

Senior Vice President and Head of the devices business unit of Emergent BioSolutions, Doug White was reportedly quoted saying that the company is delighted with the follow-on opportunity provided by the U.S. government to meet its medical countermeasures and improve the security of the nation’s diplomats and other Chief of Mission personnel involved in high-risk environments globally.

White further added that the company is looking forward to successfully deliver Trobigard auto-injector as part of the 2017 contract and to continue its collaboration with the State Department, while expanding the portfolio of solutions to address the upcoming chemical warfare agents in the long-term.

As part of the IDIQ agreement, Emergent BioSolutions would maintain the capacity to produce and deliver several medical countermeasures prescribed by the Department of State, including auto-injector training devices, Reactive Skin Decontamination Lotion Kit, and the Trobigard auto-injector.

Managing Director of operational medicine for the U.S. Department of State, William A. Walters, M.D. reportedly commented that one of the most significant responsibilities of the agency is to successfully respond to grave threats to diplomatic missions overseas and to ensure the safety of employees stationed there.

Ensuring adequate stockpiles of medical countermeasures and establishing a stable supply chain of the same is important as the department equips itself with the tools that enable an accurate, timely, and safe response to the highest risk chemical agents, Walters explained.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh    

Pankaj Singh

With an experience as an insurance underwriter and a freelance writer under his belt, Pankaj Singh boasts of quite some expertise in the field of content creation. A qualified Post Graduate in Management, Pankaj has also completed a detailed course in Digital Marketin...

Read More

More News By Pankaj Singh

Bettervest invests in Oakridge Rooftops to support solar projects
Bettervest invests in Oakridge Rooftops to support solar projects
By Pankaj Singh

Oakridge Rooftops Pvt. Ltd., a solar energy company based in India, has reportedly secured funding from Germany-based crowdfunding platform, Bettervest Gmbh. The solar firm has raised the funding for urban solar projects in New Delhi. Oakridge CEO, ...

Databricks buys 8080 Labs to boost its low code/no code offerings
Databricks buys 8080 Labs to boost its low code/no code offerings
By Pankaj Singh

California-based enterprise software company- Databricks has acquired German software startup 8080 Labs that developed bamboolib- a leading GUI for the Python-based Pandas data analysis and manipulation system. The purchase of 8080 Labs makes the fi...

Google rolls out GNI Advertising Lab for news publishers in India
Google rolls out GNI Advertising Lab for news publishers in India
By Pankaj Singh

American tech giant, Google LLC has recently announced the launch of Google News Initiative (GNI) Advertising Lab program for supporting small and medium-sized news publishers that generate original and accurate news for regional and local communitie...